cbdMD (NYSEAMERICAN:YCBD) (NYSE American: YCBD) is a manufacturer and distributor of hemp-derived cannabidiol (CBD) wellness products. The company offers a broad portfolio that includes oils and tinctures, capsules, gummies, topicals, and pet products. Utilizing broad-spectrum and isolate formulations, cbdMD focuses on delivering consistent quality and potency by working with state-licensed growers to source non-GMO hemp cultivated without pesticides or herbicides.
Products are distributed through both direct-to-consumer channels—via the company’s e-commerce platform—and through a network of brick-and-mortar retail partners. cbdMD has secured placement in national retailers, specialty health stores, and veterinary outlets, allowing its CBD oils and related items to reach a wide geographic footprint across the United States. The company’s logistics and fulfillment operations are headquartered in Charlotte, North Carolina.
Founded in 2018 by entrepreneur Fox Carlson, cbdMD launched commercially in early 2019 and completed its initial public offering on the NYSE American exchange in January 2020. Since its public listing, the company has invested in third-party testing, scientific research collaborations, and targeted marketing campaigns to build brand recognition. cbdMD’s vertically integrated approach—from seed to shelf—allows for rigorous quality control and has helped the company expand its retail footprint and e-commerce customer base.
The executive team is led by Chief Executive Officer Tim Morin, who joined the organization in 2021, alongside Chief Financial Officer Ryan Hughes. Strategic leadership also includes Chief Operating Officer Erin Marshall and Vice President of Compliance Jessica Stevens, each bringing extensive experience in consumer goods, supply chain management, and regulatory affairs. Under this leadership, cbdMD continues to prioritize product innovation, consumer education, and expansion into new market segments.
